Evidence map

ReviewDiscover mental health2023

Overview of the potential use of fluvoxamine for COVID-19 and long COVID.

Kenji HashimotoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36968793